JP2003192578A - Soft capsule - Google Patents
Soft capsuleInfo
- Publication number
- JP2003192578A JP2003192578A JP2001396643A JP2001396643A JP2003192578A JP 2003192578 A JP2003192578 A JP 2003192578A JP 2001396643 A JP2001396643 A JP 2001396643A JP 2001396643 A JP2001396643 A JP 2001396643A JP 2003192578 A JP2003192578 A JP 2003192578A
- Authority
- JP
- Japan
- Prior art keywords
- ricinoleic acid
- soft capsule
- gelatin
- acid ester
- content liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- General Preparation And Processing Of Foods (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【0001】本発明は、内容液に天然物から得られた濃
縮物の親水性粉末とポリグリセリン縮合リシノール酸エ
ステルを含有する食品、医薬品、化粧品等に利用される
ゼラチンを皮膜とする軟カプセルに関する。The present invention relates to a soft capsule containing gelatin as a film, which is used in foods, pharmaceuticals, cosmetics, etc., which contains a hydrophilic powder of a concentrate obtained from a natural product and polyglycerol condensed ricinoleic acid ester as a content liquid. .
【0002】軟カプセルは、一般に油脂、脂溶性成分等
を内容液とし、ゼラチンを皮膜とするカプセル製剤で、
食品、医薬品、化粧品等の分野で広く用いられている。
これは、軟カプセルが一定量の成分を簡便に配合でき、
内容成分を安定に保つことができる為である。最近で
は、親水性粉末を界面活性剤、安定剤等で油相に分散せ
しめた内容液を充填する方法が開発され、軟カプセルの
汎用性がさらに高まっている。Soft capsules are generally capsule preparations containing a fat and oil-soluble component as a content liquid and gelatin as a film.
Widely used in the fields of food, pharmaceuticals, cosmetics, etc.
This is because soft capsules can easily mix a certain amount of ingredients,
This is because the content components can be kept stable. Recently, a method of filling a content liquid in which a hydrophilic powder is dispersed in an oil phase with a surfactant, a stabilizer, etc. has been developed, and the versatility of soft capsules is further increasing.
【0003】しかし、親水性粉末の配合量が多くなる
と、内容液の充填時にゼラチン皮膜の接合部分に当該親
水性粉末が付着して接合部分が脆くなり、温度変化、経
時等により内容液が漏れるという問題がある。係る問題
に対処するには、ゼラチン皮膜を厚くする方法がある
が、軟カプセルの崩壊時間が著しく遅延するという重大
な欠点がある。However, when the content of the hydrophilic powder increases, the hydrophilic powder adheres to the joint portion of the gelatin film during filling of the content liquid to make the joint portion brittle, and the content liquid leaks due to temperature change, aging, etc. There is a problem. Although there is a method of thickening the gelatin film to deal with such a problem, there is a serious drawback that the disintegration time of the soft capsule is significantly delayed.
【0004】又、一般に天然物から得られた濃縮物の親
水性粉末にはアルデヒド類、ケトース、酸化物等が含ま
れる。この為、当該親水性粉末を含む内容液を軟カプセ
ルに充填すると、ゼラチンのリジン残基とアルデヒド類
やケトースの反応、或いはリジン残基の酸化によるアル
デヒド化でゼラチンが不溶化し、軟カプセルの崩壊時間
が経時的に遅延するという問題がある。崩壊時間が遅延
すると、カプセルが消化器系で溶解されず、カプセルの
内容成分が人体に吸収されない等の問題が生じる。Further, generally, the hydrophilic powder of a concentrate obtained from a natural product contains aldehydes, ketose, oxides and the like. Therefore, if a soft capsule is filled with the content liquid containing the hydrophilic powder, the gelatin becomes insoluble due to the reaction of the lysine residue of gelatin with aldehydes or ketose, or the aldehyde formation due to the oxidation of the lysine residue, resulting in disintegration of the soft capsule. There is a problem that time is delayed with time. When the disintegration time is delayed, there arises a problem that the capsule is not dissolved in the digestive system and the contents of the capsule are not absorbed by the human body.
【0005】係る問題に対処すべく、特開平8−245
372号には皮膜に酸処理ゼラチン、還元剤等を配合し
た軟カプセルが、特開2000−44465号には皮膜
に化学修飾ゼラチン及びポリグルコースを配合した軟カ
プセルが開示されているが、これらは崩壊時間の経時的
遅延は防止されるものの、当初から崩壊性そのものが悪
く、根本的な解決には至っていないのが現状である。To address such a problem, Japanese Patent Laid-Open No. 8-245
No. 372 discloses a soft capsule in which a film contains acid-treated gelatin, a reducing agent, etc., and JP-A No. 2000-44465 discloses a soft capsule in which a film contains chemically modified gelatin and polyglucose. Although the disintegration time can be prevented from being delayed with time, the disintegration itself is poor from the beginning, and a fundamental solution has not yet been reached.
【0006】この様な事情に鑑み本発明者らが鋭意検討
した結果、軟カプセルの内容液に天然物から得られた濃
縮物の親水性粉末を多量に配合しても、所定のポリグリ
セリン縮合リシノール酸エステルを含有せしめること
で、軟カプセルの経時的な液漏れ、崩壊時間の遅延等を
防止できることを見出し、本発明を完成するに至った。In view of such circumstances, as a result of intensive investigations by the present inventors, even if a large amount of hydrophilic powder of a concentrate obtained from a natural product is mixed in the content liquid of the soft capsule, a predetermined polyglycerin condensation is obtained. It has been found that the inclusion of ricinoleic acid ester can prevent the liquid leakage of the soft capsule with time, the delay of the disintegration time, and the like, and completed the present invention.
【0007】即ち、本発明は、内容液に天然物から得ら
れた濃縮物の親水性粉末を20〜50%配合した場合に
おいて、ポリグリセリン縮合リシノール酸エステル(グ
リセリン単位2〜10及びリシノール酸単位2〜10)
を0.1〜30%含有せしめることで、経時的な液漏
れ、崩壊時間の遅延等を防止するゼラチンを皮膜とする
軟カプセルである。That is, according to the present invention, when 20 to 50% of a hydrophilic powder of a concentrate obtained from a natural product is mixed in the content liquid, polyglycerin condensed ricinoleic acid ester (glycerin units 2 to 10 and ricinoleic acid unit) is added. 2-10)
It is a soft capsule containing gelatin as a film which prevents leakage of liquid over time, delay of disintegration time, etc. by containing 0.1 to 30% of.
【0008】本発明に係る天然物から得られた濃縮物の
親水性粉末とは、天然物の抽出液、搾汁、或は天然物自
体等を濃縮した親水性の粉末をいう。例えば、抽出液の
濃縮物の親水性粉末としては、高麗人参、エゾウコギ、
アガリクス、霊芝、メシマコブ、ギムネマ、アロエ、ウ
コン、イチョウ葉、桑の葉、くま笹等の生薬、大豆、
米、小麦等の穀物、緑茶、ウーロン茶、紅茶等の茶、人
参、カボチャ、ほうれん草、キャベツ等の野菜、ブルー
ベリー、ぶどう、オレンジ、りんご、みかん、レモン等
の果物、牛乳、山羊乳、羊乳等の乳、鰯、鰹、牡蠣、イ
カ等の魚介、鶏肉、豚肉、牛肉等の獣肉、プロポリス、
ローヤルゼリー等の冷水、熱水、アルコール、含水アル
コール等の抽出液を濃縮した粉末が挙げられる。搾汁の
濃縮物の親水性粉末としては、上述の生薬、野菜、果物
等の搾汁を濃縮した粉末が挙げられる。又、天然物自体
の濃縮物の親水性粉末としては、上述の生薬、穀物、
茶、野菜、果物、乳、魚介、獣肉、プロポリス、ローヤ
ルゼリー等を乾燥、濃縮、粉砕等した粉末が挙げられ
る。これらの天然物から得られた濃縮物の親水性粉末
は、必要に応じて酵素、加水分解、精製等の処理がされ
たものを用いることができる。又、天然物から得られた
濃縮物の親水性粉末は単独又は2種以上を組み合わせて
用いることができる。The hydrophilic powder of the concentrate obtained from the natural product according to the present invention means a hydrophilic powder obtained by concentrating the extract of the natural product, squeezed juice, or the natural product itself. For example, as the hydrophilic powder of the extract concentrate, ginseng, eleuthero,
Agaricus, Ganoderma lucidum, Phellinus linteus, Gymnema, Aloe, Turmeric, Ginkgo biloba, Mulberry leaf, Herbal medicine such as bear bamboo, soybean,
Grains such as rice and wheat, tea such as green tea, oolong tea, black tea, vegetables such as carrots, pumpkin, spinach, cabbage, fruits such as blueberries, grapes, oranges, apples, mandarins, lemons, milk, goat milk, sheep milk, etc. Milk, sardines, bonito, oysters, seafood such as squid, meat such as chicken, pork and beef, propolis,
Examples include powders obtained by concentrating an extract solution of cold water such as royal jelly, hot water, alcohol, hydrous alcohol and the like. Examples of the hydrophilic powder of the squeezed concentrate include powders obtained by squeezing the above-mentioned crude drugs, vegetables, fruits and the like. Further, as the hydrophilic powder of the concentrate of the natural product itself, the above-mentioned crude drug, grain,
Examples thereof include powders obtained by drying, concentrating and crushing tea, vegetables, fruits, milk, seafood, meat, propolis, royal jelly and the like. As the hydrophilic powder of the concentrate obtained from these natural products, those subjected to treatment such as enzyme, hydrolysis, and purification as necessary can be used. Further, the hydrophilic powder of the concentrate obtained from a natural product can be used alone or in combination of two or more kinds.
【0009】粉末の粒度は特に限定されないが、60メ
ッシュ以下がよく、好ましくは80メッシュ以下、さら
に好ましくは100メッシュ以下である。又、粉末の水
分量は、7%以下が好ましく、さらに好ましくは5%以
下である。The particle size of the powder is not particularly limited, but 60 mesh or less is preferable, 80 mesh or less is more preferable, and 100 mesh or less is more preferable. The water content of the powder is preferably 7% or less, more preferably 5% or less.
【0010】ポリグリセリン縮合リシノール酸エステル
は、通常、グリセリンを脱水縮合したポリグリセリン
と、ヒマシ油脂肪酸に触媒を添加して窒素ガス気流下で
180〜210℃に加熱して得られた縮合リシノール酸
を、窒素ガス気流下で180〜210℃でエステル化し
て得られるものである。ポリグリセリン縮合リシノール
酸エステルは食品、医薬品、化粧品等に広く用いられて
おり、市販品を用いることができる。本発明のポリグリ
セリン縮合リシノール酸エステルはグリセリン単位が2
〜10、リシノール酸単位が2〜10のものを用いる。
より好ましくは、グリセリン単位が4〜6、リシノール
酸単位が4〜6のものである。尚、特開平9−1639
63号には、乳化物である内容液にグリセリン単位が1
〜15のポリグリセリンとポリヒドロキシカルボン酸か
らなるエステルを用いた軟カプセルが開示されている
が、当該発明は乳化物の安定性と熱水溶解性を高めたも
のであり、本発明に係る軟カプセルを示唆するものでは
無い。The polyglycerin condensed ricinoleic acid ester is usually a condensed ricinoleic acid obtained by dehydration-condensing glycerin and polyglycerin obtained by adding a catalyst to castor oil fatty acid and heating to 180 to 210 ° C. under a nitrogen gas stream. Is obtained by esterification at 180 to 210 ° C. under a nitrogen gas stream. Polyglycerin condensed ricinoleic acid ester is widely used in foods, pharmaceuticals, cosmetics and the like, and commercially available products can be used. The polyglycerin condensed ricinoleic acid ester of the present invention has 2 glycerin units.
-10, and those having a ricinoleic acid unit of 2 to 10 are used.
More preferably, the glycerin unit is 4 to 6 and the ricinoleic acid unit is 4 to 6. Incidentally, JP-A-9-1639
No. 63 has 1 glycerin unit in the content liquid which is an emulsion.
Although soft capsules using an ester of polyglycerin and polyhydroxycarboxylic acid of No. 15 to 15 are disclosed, the present invention improves the stability and hot water solubility of the emulsion, and the soft capsule according to the present invention. It does not suggest a capsule.
【0011】本発明の内容液に天然物から得られた濃縮
物の親水性粉末とポリグリセリン縮合リシノール酸エス
テルを含有するゼラチンを皮膜とした軟カプセルは、内
容液にレシチンを配合することにより更に効果を高める
ことができる。レシチンは、大豆、卵黄等から得られる
ホスファチジルコリン、ホスファチジルエタノールアミ
ン、ホスファチジルイノシトール等を含むリン脂質であ
る。レシチンは、天然の両性イオン系界面活性剤で、食
品、医薬品、化粧品等に広く用いられており、市販品を
用いることができる。レシチンとしては大豆レシチン、
卵黄レシチンの他に、これらをアセトンで脱脂濃縮した
粉末レシチン、エタノールで分画濃縮した分画レシチ
ン、酵素的に加水分解した酵素分解レシチン等が挙げら
れ、これらは単独又は2種以上を組み合せて用いること
ができる。A soft capsule having a gelatin coating containing a hydrophilic powder of a concentrate obtained from a natural product and a polyglycerin condensed ricinoleic acid ester in the content liquid of the present invention can be further prepared by adding lecithin to the content liquid. The effect can be enhanced. Lecithin is a phospholipid containing phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and the like obtained from soybean, egg yolk and the like. Lecithin is a natural zwitterionic surfactant, which is widely used in foods, pharmaceuticals, cosmetics, etc., and commercially available products can be used. Soy lecithin as lecithin,
In addition to egg yolk lecithin, powdered lecithin obtained by degreasing and concentrating these with acetone, fractionated lecithin obtained by fractionation and concentration with ethanol, enzymatically hydrolyzed enzymatically decomposed lecithin, and the like may be mentioned. These may be used alone or in combination of two or more kinds. Can be used.
【0012】本発明に係る天然物から得られた濃縮物の
親水性粉末の内容液への配合量は、20〜50%であ
る。ポリグリセリン縮合リシノール酸エステルの配合量
は、0.1〜30%、より好ましくは0.1〜10%で
ある。又、レシチンを配合する場合は、0.1〜5%配
合するとよい。The content of the hydrophilic powder of the concentrate obtained from the natural product according to the present invention in the content liquid is 20 to 50%. The content of polyglycerin condensed ricinoleic acid ester is 0.1 to 30%, more preferably 0.1 to 10%. When lecithin is added, it is recommended to add 0.1-5%.
【0013】本発明の軟カプセルの内容液として、シソ
油、米胚芽油、小麦胚芽油、大豆油、ナタネ油、コーン
油、サフラワー油、ゴマ油、綿実油、パーム油等の植物
油脂、魚油、イカ油、鯨油、牛脂、豚脂等の動物油脂、
スクワラン、パラフィン等の炭化水素、ミツロウ、米糠
ロウ、カルナウバロウ等のワックス、ビタミン、ミネラ
ル、アミノ酸等の栄養強化剤、グリセリン脂肪酸エステ
ル、ショ糖脂肪酸エステル等の界面活性剤、ビタミン
E、ヒドロキシトルエン、ヒドロキシアニソール等の酸
化防止剤、高級アルコール等の食品、医薬品、化粧品等
に用いられているものを適宜配合することができる。As the content liquid of the soft capsule of the present invention, perilla oil, rice germ oil, wheat germ oil, soybean oil, rapeseed oil, corn oil, safflower oil, sesame oil, cottonseed oil, palm oil and other vegetable oils, fish oils, Animal fats and oils such as squid oil, whale oil, beef tallow, lard,
Hydrocarbons such as squalane and paraffin, waxes such as beeswax, rice bran wax and carnauba wax, nutritional enhancers such as vitamins, minerals and amino acids, surfactants such as glycerin fatty acid ester and sucrose fatty acid ester, vitamin E, hydroxytoluene, hydroxy Antioxidants such as anisole, those used in foods such as higher alcohols, pharmaceuticals, cosmetics and the like can be appropriately mixed.
【0014】本発明に係るゼラチン皮膜は、ゼラチンに
グリセリン、ソルビット等の可塑剤を配合したものを基
剤とする。ゼラチン、可塑剤の種類及び配合比は、目的
とする軟カプセルの大きさ、形状等を考慮して適宜選択
する。又、必要に応じて色素等の添加剤を配合すること
ができる。ゼラチンは、アルカリ処理ゼラチン、酸処理
ゼラチン、酵素処理ゼラチン、化学修飾ゼラチン等の食
品、医薬品、化粧品等で用いられているものを適宜選択
して用いることができる。The gelatin film according to the present invention is based on a mixture of gelatin with a plasticizer such as glycerin or sorbit. The type and blending ratio of gelatin and plasticizer are appropriately selected in consideration of the size and shape of the intended soft capsule. If necessary, additives such as dyes can be added. As the gelatin, those used in foods, pharmaceuticals, cosmetics and the like such as alkali-treated gelatin, acid-treated gelatin, enzyme-treated gelatin and chemically modified gelatin can be appropriately selected and used.
【0015】本発明に係る内容液の調製は、一般的な方
法に従えばよい。例えば、油脂、ポリグリセリン縮合リ
シノール酸エステル、ワックス等を60〜80℃で加熱
溶解して30〜50℃まで冷却する。これに天然物から
得られた濃縮物の親水性粉末、レシチン、酸化防止剤等
を添加してホモミキサー等の高速攪拌機で均一に混合し
た後、マイコロイダー等の粉砕機で粉砕して篩過し、減
圧下で脱泡して内容液を得る。The content liquid according to the present invention may be prepared by a general method. For example, oil and fat, polyglycerin condensed ricinoleic acid ester, wax and the like are heated and dissolved at 60 to 80 ° C and cooled to 30 to 50 ° C. To this, add hydrophilic powder of concentrate obtained from natural product, lecithin, antioxidant, etc. and mix evenly with a high-speed stirrer such as homomixer, and then grind with a grinder such as Mycoloider and sieve. Then, defoaming is performed under reduced pressure to obtain a content liquid.
【0016】軟カプセルの成形は、ロータリー法、平板
法、2重ノズル法等の一般的な方法に従えばよいが、特
にロータリー法及び平板法による軟カプセルにおいて本
発明の効果が発揮される。ロータリー法による軟カプセ
ルの成形は、例えば、内容液を送る定量ポンプ、ゼラチ
ンシートを送るローラー、打ち抜き型等を装備したロー
タリー式カプセル成形機を用い、内容液の充填、ゼラチ
ンシートの圧着接合及びカプセル成形を同時に行う。そ
の後、回転ドラム式乾燥機で皮膜水分を10%以下にな
るまで乾燥し、軟カプセルを得る。The soft capsules may be molded by a general method such as a rotary method, a flat plate method or a double nozzle method, but the effect of the present invention is exerted particularly in the soft capsules by the rotary method or the flat plate method. For molding soft capsules by the rotary method, for example, a rotary capsule molding machine equipped with a metering pump for feeding the content liquid, a roller for feeding the gelatin sheet, a punching die, etc. is used to fill the content liquid, press-bond the gelatin sheet and form the capsule. Simultaneous molding. Then, the film moisture is dried by a rotary drum dryer until the water content in the film is 10% or less, to obtain soft capsules.
【0017】次に本発明を詳細に説明するために代表的
な実施例を挙げるが、本発明はこれに限定されるもので
はない。実施例に示す配合量は重量%を示す。Next, typical examples will be given to explain the present invention in detail, but the present invention is not limited thereto. The compounding amounts shown in the examples are% by weight.
【0018】
実施例1
<処方> 配合量(
%)
1.シソ油 51.0
2.ポリグリセリン縮合リシノール酸エステル 3.0
(グリセリン単位6、リシノール酸単位5.5)
3.ミツロウ 12.0
4.ビタミンE 3.0
5.大豆レシチン 1.0
6.霊芝の熱水抽出物の粉末(粒度80メッシュ以下、水分4.5%)30.0
<製法>成分1〜3を70℃で加熱溶解して40℃まで
冷却した後、成分4〜6を添加してホモミキサー(20
00rpm)で30分間混合し、マイコロイダーで粉砕
して83メッシュ(目開き180μm)で篩過する。さ
らに720mmHg減圧下で脱泡したものを内容液とし
た。皮膜液は、ゼラチン100部、グリセリン35部及
び精製水80部を加熱溶解したものを使用し、ロータリ
ー式カプセル成形機にて内容液を充填して成形し、回転
ドラム式乾燥機で皮膜水分が7%になるまで乾燥し、全
重量550mg、内容液量360mgの楕円形軟カプセ
ルを得た。Example 1 <Prescription> Blending amount (%) 1. Perilla oil 51.0 2. Polyglycerin condensed ricinoleic acid ester 3.0 (glycerin unit 6, ricinoleic acid unit 5.5) 3. Beeswax 12.0 4. Vitamin E 3.0 5. Soy lecithin 1.0 6. Powder of hot water extract of Ganoderma lucidum (particle size 80 mesh or less, water content 4.5%) 30.0 <Production method> Components 1 to 3 are heated and melted at 70 ° C. and cooled to 40 ° C., and then components 4 to 6 Add homomixer (20
(00 rpm) for 30 minutes, crushed with Mycoloider, and sieved with 83 mesh (opening 180 μm). Further, what was defoamed under a reduced pressure of 720 mmHg was used as a content liquid. The coating solution used is 100 parts of gelatin, 35 parts of glycerin and 80 parts of purified water heated and dissolved, and the content solution is filled with a rotary capsule molding machine to form a film. It was dried to 7% to obtain an elliptical soft capsule having a total weight of 550 mg and a content liquid amount of 360 mg.
【0019】実施例1のポリグリセリン縮合リシノール
酸エステル(グリセリン単位6及びリシノール酸単位
5.5)のグリセリン単位或いはリシノール酸単位を表
1の重合単位のものに置き換えて得た軟カプセルを実施
例2〜4、比較例1〜3とした。A soft capsule obtained by replacing the glycerin unit or the ricinoleic acid unit of the polyglycerin-condensed ricinoleic acid ester (glycerin unit 6 and ricinoleic acid unit 5.5) of Example 1 with the polymerized unit of Table 1 was used as an Example. 2 to 4 and Comparative Examples 1 to 3.
【0020】[0020]
【表1】 [Table 1]
【0021】実施例1のポリグリセリン縮合リシノール
酸エステルの配合量を表2の通りに変えて、全体量をシ
ソ油で調整して得た軟カプセルを実施例5〜7及び比較
例4とした。Soft capsules obtained by adjusting the total amount of polyglycerin condensed ricinoleic acid ester of Example 1 as shown in Table 2 and adjusting the total amount with perilla oil were designated as Examples 5 to 7 and Comparative Example 4. .
【0022】[0022]
【表2】 [Table 2]
【0023】ポリグリセリン縮合リシノール酸エステル
を、表3のグリセリンモノ脂肪酸エステル或いは脂肪酸
が縮合リシノール酸以外の脂肪酸であるポリグリセリン
脂肪酸エステルに置き換えて得た軟カプセルを比較例5
〜10とした。Comparative Example 5 was a soft capsule obtained by replacing the polyglycerin condensed ricinoleic acid ester with a glycerin monofatty acid ester of Table 3 or a polyglycerin fatty acid ester whose fatty acid is a fatty acid other than condensed ricinoleic acid.
It was set to 10.
【0024】[0024]
【表3】 [Table 3]
【0025】実施例8
実施例1において、大豆レシチンをシソ油に置き換えた
ものを実施例8とした。Example 8 Example 8 was the same as Example 1 except that soybean lecithin was replaced with perilla oil.
【0026】
実施例9
<処方> 配合量(
%)
1.米胚芽油 50.0
2.ポリグリセリン縮合リシノール酸エステル 2.0
(グリセリン単位6、リシノール酸単位5.5)
3.ミツロウ 4.5
4.ビタミンE 3.0
5.大豆レシチン 0.5
6.ブルーベリー果汁の含水アルコール抽出物の粉末 40.0
(粒度80メッシュ以下、水分3.4%)
<製法>成分1〜3を70℃で加熱溶解して40℃まで
冷却した後、成分4〜6を添加してホモミキサー(20
00rpm)で30分間混合した後、マイコロイダーで
粉砕して83メッシュ(目開き180μm)で篩過す
る。さらに720mmHg減圧下で脱泡したものを内容
液とした。皮膜液は、ゼラチン100部、グリセリン3
5部及び精製水80部を加熱溶解したものを使用し、ロ
ータリー式カプセル成形機にて内容液を充填して成形
し、回転ドラム式乾燥機で皮膜水分が8%になるまで乾
燥し、全重量550mg、内容液量360mgの楕円形
軟カプセルを得た。Example 9 <Prescription> Compounding amount (%) 1. Rice germ oil 50.0 2. Polyglycerin condensed ricinoleic acid ester 2.0 (glycerin unit 6, ricinoleic acid unit 5.5) 3. Beeswax 4.5 4. Vitamin E 3.0 5. Soy lecithin 0.5 6. Powder of hydroalcoholic extract of blueberry juice 40.0 (particle size 80 mesh or less, water content 3.4%) <Production method> Components 1 to 3 are heated and dissolved at 70 ° C and cooled to 40 ° C, and then components 4 to 6 are prepared. Add homomixer (20
After mixing at 00 rpm) for 30 minutes, it is crushed with Mycoloider and sieved with 83 mesh (opening 180 μm). Further, what was defoamed under a reduced pressure of 720 mmHg was used as a content liquid. The coating solution is 100 parts of gelatin and 3 glycerin.
Using 5 parts and 80 parts of purified water heated and dissolved, the content liquid was filled with a rotary capsule molding machine to mold and dried with a rotary drum dryer until the film moisture became 8%, An elliptical soft capsule having a weight of 550 mg and a content liquid amount of 360 mg was obtained.
【0027】
実施例10
<処方> 配合量(
%)
1.コーン油 53.0
2.ポリグリセリン縮合リシノール酸エステル 1.5
(グリセリン単位6、リシノール酸単位5.5)
3.ミツロウ 7.0
4.ビタミンE 3.0
5.大豆レシチン 0.5
6.アガリクスの熱水抽出物の粉末 35.0
(粒度80メッシュ以下、水分4.3%)
<製法>成分1〜3を70℃で加熱溶解して40℃まで
冷却した後、成分4〜6を添加してホモミキサー(20
00rpm)で30分間混合した後、マイコロイダーで
粉砕して83メッシュ(目開き180μm)で篩過す
る。さらに720mmHg減圧下で脱泡したものを内容
液とした。皮膜液は、ゼラチン100部、グリセリン3
5部及び精製水80部を加熱溶解したものを使用し、ロ
ータリー式カプセル成形機にて内容液を充填して成形
し、回転ドラム式乾燥機で皮膜水分が7%になるまで乾
燥し、全重量480mg、内容液量250mgの楕円形
軟カプセルを得た。Example 10 <Prescription> Compounding amount (%) 1. Corn oil 53.0 2. Polyglycerin condensed ricinoleic acid ester 1.5 (glycerin unit 6, ricinoleic acid unit 5.5) 3. Beeswax 7.0 4. Vitamin E 3.0 5. Soy lecithin 0.5 6. Powder of hot water extract of Agaricus 35.0 (particle size 80 mesh or less, water content 4.3%) <Production method> Components 1 to 3 were heated and dissolved at 70 ° C and cooled to 40 ° C, and then components 4 to 6 were added. Add the homomixer (20
After mixing at 00 rpm) for 30 minutes, it is crushed with Mycoloider and sieved with 83 mesh (opening 180 μm). Further, what was defoamed under a reduced pressure of 720 mmHg was used as a content liquid. The coating solution is 100 parts of gelatin and 3 glycerin.
Using 5 parts and 80 parts of purified water heated and dissolved, the content liquid was filled with a rotary capsule molding machine and molded, and dried with a rotary drum dryer until the film moisture became 7%, Oval soft capsules having a weight of 480 mg and a content liquid amount of 250 mg were obtained.
【0028】以下の実験例にて、本発明の効果を詳細に
説明する。実施例1〜8及び比較例1〜10の軟カプセ
ルを夫々1000粒づつガラスの密閉容器に入れ、40
℃で2ヶ月保存後の軟カプセルの液漏れ、割れ、崩壊時
間を観察した。尚、液漏れ及び割れは目視で、崩壊時間
は日本薬局方の崩壊試験法(試験液は精製水、n=6、
補助盤使用)に準じて行った。The effects of the present invention will be described in detail in the following experimental examples. 1000 soft capsules of each of Examples 1 to 8 and Comparative Examples 1 to 10 were placed in a glass closed container, and
The liquid leakage, cracking and disintegration time of the soft capsules after storage for 2 months at ℃ were observed. Liquid leakage and cracks were visually observed, and the disintegration time was determined by the disintegration test method of the Japanese Pharmacopoeia (test liquid: purified water, n = 6,
It was performed according to (using an auxiliary board).
【0029】経時的な液漏れ及び割れの発生数、崩壊時
間を表4に示す。本発明に係る実施例1〜8の軟カプセ
ルは、何れも経時的な液漏れ及び割れを生じず、又、崩
壊時間の遅延が防止されている。特にグリセリン単位が
4〜6及びリシノール酸単位が4〜6のポリグリセリン
縮合リシノール酸エステルと大豆レシチンを併用した実
施例において、優れた崩壊時間の遅延防止効果が得られ
ている。一方、他の界面活性剤を用いた軟カプセルは経
時的な液漏れ或いは割れを生じ、崩壊時間が遅延してい
るのがわかる。尚、表4中のEは天然物から得られた濃
縮物の親水性粉末、Rはポリグリセリン縮合リシノール
酸エステル、Dは大豆レシチンを示す。Table 4 shows the number of liquid leaks and cracks generated over time and the disintegration time. In each of the soft capsules of Examples 1 to 8 according to the present invention, liquid leakage and cracking with time do not occur, and delay of disintegration time is prevented. In particular, in Examples in which polyglycerin condensed ricinoleic acid ester having 4 to 6 glycerin units and 4 to 6 ricinoleic acid units and soybean lecithin were used in combination, an excellent effect of preventing delay of disintegration time was obtained. On the other hand, it can be seen that soft capsules using other surfactants cause liquid leakage or cracking over time, and the disintegration time is delayed. In Table 4, E represents hydrophilic powder of a concentrate obtained from a natural product, R represents polyglycerin condensed ricinoleic acid ester, and D represents soybean lecithin.
【0030】[0030]
【表4】 [Table 4]
【0031】以上の結果から、内容液に天然物から得ら
れた濃縮物の親水性粉末を20〜50%、ポリグリセリ
ン縮合リシノール酸エステル(グリセリン単位2〜10
及びリシノール酸単位2〜10)を0.1〜30%含有
することを特徴とするゼラチンを皮膜とする軟カプセル
は、経時的に液漏れ及び割れを生じず、崩壊時間が遅延
しにくいことが証明された。又、当該構成にレシチンを
0.1〜5%配合することによりさらに優れた効果が得
られることが明らかとなった。From the above results, 20 to 50% of hydrophilic powder of the concentrate obtained from the natural product in the content liquid, polyglycerin condensed ricinoleic acid ester (glycerin unit 2 to 10)
And a gelatin-coated soft capsule characterized by containing 0.1 to 30% of ricinoleic acid units 2 to 10) does not cause liquid leakage or cracking over time, and is unlikely to delay disintegration time. Proved. Further, it has been clarified that a more excellent effect can be obtained by adding lecithin to the composition in an amount of 0.1 to 5%.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4B035 LE07 LG04 LG13 LG31 LG41 LP36 4C076 AA56 BB01 CC07 CC23 DD63Q EE24Q EE42 EE53 EE54 FF65 ─────────────────────────────────────────────────── ─── Continued front page F-term (reference) 4B035 LE07 LG04 LG13 LG31 LG41 LP36 4C076 AA56 BB01 CC07 CC23 DD63Q EE24Q EE42 EE53 EE54 FF65
Claims (3)
性粉末を20〜50%、ポリグリセリン縮合リシノール
酸エステル(グリセリン単位2〜10及びリシノール酸
単位2〜10)を0.1〜30%含有することを特徴と
するゼラチンを皮膜とする軟カプセル。1. A content liquid containing 20 to 50% hydrophilic powder of a concentrate obtained from a natural product and 0.1% polyglycerin condensed ricinoleic acid ester (glycerin units 2 to 10 and ricinoleic acid units 2 to 10). A soft capsule containing gelatin as a coating, characterized in that the soft capsule contains -30%.
ことを特徴とする請求項1記載の軟カプセル。2. The soft capsule according to claim 1, wherein the content liquid contains 0.1 to 5% of lecithin.
のグリセリン単位が4〜6及びリシノール酸単位が4〜
6である請求項1又は2記載の軟カプセル。3. A polyglycerin condensed ricinoleic acid ester having 4 to 6 glycerin units and 4 to 6 ricinoleic acid units.
6. The soft capsule according to claim 1 or 2, which is 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001396643A JP4156234B2 (en) | 2001-12-27 | 2001-12-27 | Soft capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001396643A JP4156234B2 (en) | 2001-12-27 | 2001-12-27 | Soft capsule |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2003192578A true JP2003192578A (en) | 2003-07-09 |
JP4156234B2 JP4156234B2 (en) | 2008-09-24 |
Family
ID=27602683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001396643A Expired - Lifetime JP4156234B2 (en) | 2001-12-27 | 2001-12-27 | Soft capsule |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4156234B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005077419A1 (en) * | 2004-02-17 | 2005-08-25 | Eisai Co., Ltd. | Soft capsule preparation |
JP2006008654A (en) * | 2003-11-21 | 2006-01-12 | Wakunaga Pharmaceut Co Ltd | Capsule, method for producing capsule, and capsule wall |
JP2006328038A (en) * | 2004-07-30 | 2006-12-07 | Wakunaga Pharmaceut Co Ltd | Composition for capsule film, capsule film, capsular preparation using the same, and method for producing the capsular preparation |
JP2008094805A (en) * | 2006-10-16 | 2008-04-24 | Kao Corp | Manufacturing method of polyglycerin condensed-ricinoleic acid ester |
WO2011027605A1 (en) * | 2009-09-07 | 2011-03-10 | 理研ビタミン株式会社 | Liquid composition to be filled in soft capsules |
JP2012051945A (en) * | 2003-11-21 | 2012-03-15 | Wakunaga Pharmaceut Co Ltd | Capsule, method for manufacturing the same, and capsule wall |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6112632A (en) * | 1984-06-27 | 1986-01-21 | Eisai Co Ltd | Composition containing fat-soluble drug |
JPS63132826A (en) * | 1986-08-29 | 1988-06-04 | アール ピー シーラー コーポレーション | Ethanol filled medicine for soft gel containing vitamins, dietary supplementary foods or like |
JPH0353873A (en) * | 1989-07-19 | 1991-03-07 | Kotobuki Akad:Kk | Soft capsule |
JPH08245372A (en) * | 1995-03-13 | 1996-09-24 | Fuji Capsule Kk | Capsule agent |
JPH10174861A (en) * | 1996-12-19 | 1998-06-30 | Lion Corp | Microcapsule and production of microcapsule |
JPH10230158A (en) * | 1997-02-21 | 1998-09-02 | Lion Corp | Manufacture of microcapsule |
JP2000044465A (en) * | 1998-05-28 | 2000-02-15 | Fuji Capsule Kk | Soft capsule agent |
JP2000079337A (en) * | 1998-09-07 | 2000-03-21 | Lion Corp | Microcapsule and its manufacture |
-
2001
- 2001-12-27 JP JP2001396643A patent/JP4156234B2/en not_active Expired - Lifetime
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6112632A (en) * | 1984-06-27 | 1986-01-21 | Eisai Co Ltd | Composition containing fat-soluble drug |
JPS63132826A (en) * | 1986-08-29 | 1988-06-04 | アール ピー シーラー コーポレーション | Ethanol filled medicine for soft gel containing vitamins, dietary supplementary foods or like |
JPH0353873A (en) * | 1989-07-19 | 1991-03-07 | Kotobuki Akad:Kk | Soft capsule |
JPH08245372A (en) * | 1995-03-13 | 1996-09-24 | Fuji Capsule Kk | Capsule agent |
JPH10174861A (en) * | 1996-12-19 | 1998-06-30 | Lion Corp | Microcapsule and production of microcapsule |
JPH10230158A (en) * | 1997-02-21 | 1998-09-02 | Lion Corp | Manufacture of microcapsule |
JP2000044465A (en) * | 1998-05-28 | 2000-02-15 | Fuji Capsule Kk | Soft capsule agent |
JP2000079337A (en) * | 1998-09-07 | 2000-03-21 | Lion Corp | Microcapsule and its manufacture |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006008654A (en) * | 2003-11-21 | 2006-01-12 | Wakunaga Pharmaceut Co Ltd | Capsule, method for producing capsule, and capsule wall |
JP2012051945A (en) * | 2003-11-21 | 2012-03-15 | Wakunaga Pharmaceut Co Ltd | Capsule, method for manufacturing the same, and capsule wall |
WO2005077419A1 (en) * | 2004-02-17 | 2005-08-25 | Eisai Co., Ltd. | Soft capsule preparation |
US7867513B2 (en) | 2004-02-17 | 2011-01-11 | Eisai R&D Management Co., Ltd. | Soft capsule |
JP2006328038A (en) * | 2004-07-30 | 2006-12-07 | Wakunaga Pharmaceut Co Ltd | Composition for capsule film, capsule film, capsular preparation using the same, and method for producing the capsular preparation |
JP2006328044A (en) * | 2004-07-30 | 2006-12-07 | Wakunaga Pharmaceut Co Ltd | Composition for gelatin film, composition for capsule film, capsule film, capsular preparation using the same, and method for producing the capsular preparation |
JP2008094805A (en) * | 2006-10-16 | 2008-04-24 | Kao Corp | Manufacturing method of polyglycerin condensed-ricinoleic acid ester |
WO2011027605A1 (en) * | 2009-09-07 | 2011-03-10 | 理研ビタミン株式会社 | Liquid composition to be filled in soft capsules |
Also Published As
Publication number | Publication date |
---|---|
JP4156234B2 (en) | 2008-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101641087B (en) | Vegetarian microcapsules | |
EP0648076B1 (en) | A microencapsulated oil or fat product | |
EP1736532A1 (en) | Method for producing calcium component powder containing oil-soluble substance | |
EP3302105B1 (en) | Microencapsulates containing stabilised lipid, and methods for the production thereof | |
EP0266323A1 (en) | Tablet containing gamma-linolenic acid, eicosa pentaenoic acid and/or docosahexaenoic acid, and method for its manufacturing | |
JP5997856B2 (en) | Method for producing oral composition | |
CN103445169A (en) | Instant germ mixing powder and preparation method thereof | |
CN108782780A (en) | A kind of linseed oil microcapsules and its production method | |
JP2006306825A (en) | STABILIZED alpha-LIPOIC ACID COMPOSITION AND ITS USE | |
JP5066670B2 (en) | Anti-obesity agent and edible composition | |
JP4156234B2 (en) | Soft capsule | |
JP2000026283A (en) | Powder composition containing oily composition | |
JP2013209493A (en) | Powdery oil and fat, method for producing the same, powdery oil and fat-containing food, powdery oil and fat-containing oral medicinal product, and method for producing the powdery oil and fat-containing food | |
JP4913340B2 (en) | Capsule | |
JP2019135217A (en) | Powder composition, method for producing powder composition, dry eye improving agent, skin quality improving agent, food and drink, cosmetic, and pet food | |
JPH10215786A (en) | Feed having good oxidation stability | |
JP6753618B2 (en) | Composition for suppressing increase in triglyceride in blood | |
JP7016810B2 (en) | A mixed edible composition of liquid oil and powder raw materials, and a method for producing the same. | |
WO2021178291A1 (en) | Undenatured type ii collagen in food and beverage applications and uses thereof | |
JP6518744B2 (en) | Oral composition | |
JP6241631B2 (en) | Oral composition | |
JP4207450B2 (en) | Polyglycerin fatty acid ester used as a dispersant for dispersing a fat and oil-insoluble compound in an oily medium, and a dispersion using the same | |
RU2142240C1 (en) | Biologically-active additive | |
JP4310567B2 (en) | Blood lipid improver | |
JP6010482B2 (en) | Oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041117 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041203 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080701 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080709 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110718 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4156234 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140718 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |